Experience relating to pregnancy, lactation, and the after-weaning condition of hyperprolactinemic patients treated with bromocriptine.
Godó
G
G
Department of Obstetrics and Gynaecology, Albert Szent-Gyorgyi University Medical School, Szeged, Hungary.
Koloszár
S
S
Szilágyi
I
I
Daru
J
J
Sas
M
M
D000328:Adult; D001971:Bromocriptine / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006966:Hyperprolactinemia / Q000188:drug therapy*; D007774:Lactation / Q000187:drug effects*; D008598:Menstruation / Q000187:drug effects; D010911:Pituitary Neoplasms / Q000188:drug therapy / Q000503:physiopathology; D049590:Postpartum Period / Q000097:blood / Q000187:drug effects*; D011247:Pregnancy / Q000097:blood / Q000187:drug effects*; D011388:Prolactin / Q000097:blood; D015175:Prolactinoma / Q000188:drug therapy / Q000503:physiopathology; D014886:Weaning
D001971:Bromocriptine; D011388:Prolactin